RHEUMATOID ARTHRITIS
Autoimmune disease
Rheumatoid arthritis:
Studies have shown that mesenchymal stem cells can modulate the immune response, reduce joint inflammation and promote cartilage regeneration in animal models of rheumatoid arthritis and in clinical trials, which may result in a decrease in symptoms and disease progression.
Systemic lupus erythematosus (SLE):
Mesenchymal stem cells have shown immunomodulatory and anti-inflammatory effects that may help control the autoimmune response and reduce inflammation in patients with systemic lupus erythematosus, thereby improving symptoms and quality of life.
Crohn's disease:
Mesenchymal stem cells have been found to have anti-inflammatory and intestinal tissue repair-promoting properties, which may be beneficial in the treatment of Crohn's disease by reducing inflammation and promoting healing of lesions in the intestine.
Thyroiditis:
Preliminary studies suggest that mesenchymal stem cells may have beneficial effects in the treatment of autoimmune thyroiditis by modulating the immune response and reducing inflammation in the thyroid gland, which may improve thyroid function and associated symptoms.
Sjögren's disease:
Although still in the research stages, preliminary studies have been conducted suggesting that mesenchymal stem cells may have beneficial effects in the treatment of Sjögren's disease by reducing inflammation in the salivary and lacrimal glands, which could improve symptoms of dryness and discomfort.
Chronic inflammatory ulcerative colitis:
Mesenchymal stem cells have been shown to have anti-inflammatory and healing-promoting properties in intestinal tissue, which may be beneficial in the treatment of ulcerative colitis by reducing inflammation and promoting regeneration of the colon lining.
General Information
A blood sample from the patient is required at least 3 hours before the procedure to sensitize the MSC’s with the patient’s serum. Preferably take a blood sample 1 day before. When the patient is local and only has treatment with MSC’s, it may be easier to schedule the patient to come for sampling one day prior to their MSC’s treatment.
*Important; patients must pay in full 5 days prior to their scheduled treatment date to ensure fresh mesenchymal stem cells.
None of the patients have had any side effects as a result of the administration of mesenchymal stem cells.
